查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1782001

抗菌素抗藥性診斷市場（依產品類型、病原體類型、技術、最終用途、國家和地區）－2025 年至 2032 年全球產業分析、市場規模、市場佔有率及預測

Antimicrobial Resistance Diagnostics Market, By Product Type, By Pathogen Type, By Technology, By End Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 288 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告重點

2024 年抗菌素抗藥性診斷市場規模價值 46.1022 億美元，2025 年至 2032 年的複合年成長率為 6.90%。

抗菌素抗藥性診斷市場-市場動態

更多採用快速和即時診斷技術，以便及時做出治療決策

快速即時診斷技術 (POC) 在對抗抗生素抗藥性方面發揮著至關重要的作用，它使醫護人員能夠快速識別抗藥性感染並相應地制定治療方案。與可能需要數天時間的傳統實驗室檢測不同，這些先進的診斷技術可在數分鐘或數小時內提供結果，有助於防止抗生素的過度使用和濫用。

根據世界衛生組織 (WHO) 2023 年的報告，快速診斷技術的應用已被證明可減少高達 30-40% 的不必要抗生素處方，顯著抑制抗藥性的產生。此外，更快、更準確的檢測有助於及時進行針對性治療，減少住院時間，並抑制醫療機構內感染的傳播，從而改善患者預後。攜帶式即時診斷 (POC) 設備的日益普及也確保即使在偏遠和資源有限的環境中也能獲得關鍵的診斷能力，從而支持全球遏制抗菌素抗藥性的努力。

例如，

2025年3月，雅培實驗室推出了一款新型快速分子診斷檢測，能夠在一小時內檢測出多種抗菌素抗藥性病原體。此檢測能夠快速識別和隔離抗藥性感染，從而加強醫院感染控制，改善病患管理和抗生素管理。

抗菌素抗藥性診斷市場—關鍵見解

根據我們的研究分析師的分析，預測期內（2025-2032 年）全球市場預計年複合成長率約為 6.90%

根據產品類型細分，預計試劑和耗材將在 2024 年佔據最大市場佔有率

根據病原體類型細分，耐甲氧西林金黃色葡萄球菌 (MRSA) 是 2024 年的主要病原體類型

根據技術細分，聚合酶鍊式反應（PCR）是2024年的領先技術

根據最終用途細分，醫院是 2024 年的主要最終用途

按地區分類，北美是 2024 年的主要收入來源

抗菌素抗藥性診斷市場-細分分析：

全球抗菌素抗藥性診斷市場根據產品類型、病原體類型、技術、最終用途和地區進行細分。

依產品類型，市場分為兩類：試劑耗材和儀器。試劑耗材領域佔據市場主導地位。這些組件對於檢測過程至關重要，不像儀器那樣可能偶爾才購買。每項診斷測試都需要試劑耗材，這意味著持續可靠的需求。醫療機構和實驗室始終在尋找補充供應，以確保其檢測操作順利進行。試劑耗材適用於不同的診斷平台，包括分子診斷、免疫測定和培養為基礎的方法。這種廣泛的兼容性增加了它們在各種檢測環境中的使用。因此，醫院、診斷實驗室和即時診斷機構始終需要這些產品。診斷領域的新技術通常會催生針對特定測試的新型試劑，進一步促進市場成長。試劑耗材的定價模式對製造商有利，因為耗材能帶來穩定的收入，而儀器的銷售頻率則較低。

根據最終用途，市場可分為五類：醫院、診斷實驗室、製藥和生物技術公司、研究機構及其他。醫院業佔據市場主導地位，這源於醫院是主要的醫療機構，經常診斷和治療感染。由於醫院內感染風險高，且迫切需要控制抗菌藥物抗藥性，醫院在先進的診斷工具方面投入大量資金，以確保及時準確地檢測抗藥性病原體。此外，醫院通常擁有實施先進抗菌藥物抗藥性診斷的基礎設施、訓練有素的人員和資金，從而推動了巨大的需求。醫院在感染控制項目和抗生素管理中發揮的作用進一步凸顯了其作為該市場關鍵最終用戶的重要性。

抗菌素抗藥性診斷市場—地理洞察

北美在全球抗菌素抗藥性診斷市場佔據主導地位，2024 年市佔率為 45.71%。

北美仍是抗菌抗藥性診斷領域規模最大、最成熟的市場，得益於其先進的醫療基礎設施、廣泛的研發活動以及高昂的醫療支出。領先的診斷公司、全面的抗菌藥物管理計畫以及政府支持的措施（例如美國國家抗擊抗生素抗藥性細菌行動計畫）加速了先進診斷工具的普及。該地區的醫院和臨床實驗室優先考慮早期準確檢測抗藥性病原體，以改善患者預後並減少院內感染。此外，強力的報銷框架和監管支持鼓勵對創新診斷技術的投資，從而進一步推動市場成長。

預計在 2024 年預測期內，亞太地區抗菌素抗藥性診斷市場的複合年成長率最高。

同時，亞太地區是成長最快的市場，這得益於人口快速成長、城市化進程加快以及抗藥性菌株感染率上升等一系列因素的共同作用。中國、印度、日本和韓國等國正顯著改善醫療基礎設施，更加重視傳染病的管理和診斷能力。該地區各國政府正在積極進行宣傳活動，並實施監測和控制抗菌藥物抗藥性的政策，這刺激了對快速且經濟高效的診斷解決方案的需求。此外，中產階級人口的不斷成長以及醫療設施可近性的改善，使得尋求及時診斷和治療的患者群體更加龐大。多重抗藥性細菌感染盛行率的上升、醫療資金的增加以及本地和國際診斷公司之間的合作，這些因素共同構成了亞太地區未來十年成長前景強勁、潛力巨大的市場。

抗菌素抗藥性診斷市場-競爭格局：

抗菌素抗藥性 (AMR) 診斷市場競爭激烈，多家全球和地區企業專注於創新、策略合作和產品發布，以鞏固其市場地位。領先的公司在研發方面投入巨資，旨在推出快速、準確且經濟高效的診斷解決方案，以滿足日益成長的及時檢測抗藥性病原體的需求。

市場的主要參與者包括羅氏診斷、雅培實驗室、生物梅里埃、丹納赫集團（Cepheid）、凱傑和賽默飛世爾科技。這些公司利用其廣泛的產品組合和強大的分銷網路來保持競爭優勢。他們還與醫療機構和政府合作，以擴大市場覆蓋範圍並支持抗菌藥物抗藥性監測計畫。

該市場以頻繁的技術進步為標誌，例如多重分子檢測和即時檢測平台的開發，這些技術能夠提供更快、更精確的結果。此外，併購也是增強能力和進入新市場的常用策略。總而言之，競爭推動持續創新，確保在對抗抗菌素抗藥性的鬥爭中，獲得更高的診斷準確性和患者治療效果。

最新動態：

2025年3月，生物梅里埃VITEK COMPACT PRO獲得FDA 510(k)認證，這是一款結合微生物鑑定和抗生素敏感性測試的新一代系統。該系統的推出增強了臨床實驗室快速檢測抗藥性病原體的能力，從而支持針對性治療，並改善患者管理，共同對抗抗菌藥物抗藥性。

2024年7月，凱傑宣布與一家全球醫療保健提供者合作，在區域診所部署其QIAstat-Dx分析儀，用於快速抗菌藥物抗藥性診斷。此次合作旨在提高傳統醫院環境之外快速且準確的抗藥性檢測的可近性，支持早期介入。

2024年9月，賽默飛世爾科技推出了一款基於PCR的新型診斷試劑盒，旨在快速檢測醫院環境中的抗菌藥物抗藥性病原體。這項創新技術能夠提供快速、準確的檢測方法，這對於有效的抗生素管理至關重要，從而鞏固了賽默飛世爾科技在抗菌藥物抗藥性診斷領域的地位。

2022年7月，領先的研發驅動生物製藥公司勃林格殷格翰與生命科學公司Evotec SE和生物梅里埃宣布成立合資企業，共同開發下一代抗菌藥物和可操作的診斷方法，以對抗抗菌藥物抗藥性。此次合作有助於該公司拓展其抗菌藥物抗藥性診斷產品線。

目錄

第1章：抗菌素抗藥性診斷市場概述

  • 研究範圍
  • 市場估計年限

第2章：執行摘要

  • 市場片段
    • 抗菌素抗藥性診斷市場片段（按產品類型）
    • 抗菌素抗藥性診斷市場片段（按病原體類型）
    • 抗菌素抗藥性診斷市場（按技術）
    • 抗菌素抗藥性診斷市場片段（依最終用途）
    • 抗菌素抗藥性診斷市場（按國家/地區）
    • 抗菌素抗藥性診斷市場（按地區）
  • 競爭洞察

第3章：抗菌素抗藥性診斷關鍵市場趨勢

  • 抗菌素抗藥性診斷市場促進因素
    • 市場促進因素的影響分析
  • 抗菌素抗藥性診斷市場限制
    • 市場限制的影響分析
  • 抗菌素抗藥性診斷市場機會
  • 抗菌素抗藥性診斷市場未來趨勢

第4章：抗菌素抗藥性診斷產業研究

  • PESTEL分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章：抗菌素抗藥性診斷市場：地緣政治緊張局勢升級的影響

  • COVID-19 疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：抗菌素抗藥性診斷市場格局

  • 2024年抗菌素抗藥性診斷市場佔有率分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第7章：抗菌素抗藥性診斷市場－依產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 試劑和耗材
    • 儀器

第 8 章：抗菌素抗藥性診斷市場 - 按病原體類型

  • 概述
    • 按病原體類型分類的細分佔有率分析
    • 艱難梭菌（CD）
    • 抗藥性彎曲桿菌（DRC）
    • 抗藥性淋病奈瑟菌（DRNG）
    • 抗藥性肺炎鏈球菌 (DRSP)
    • 抗甲氧西林金黃色葡萄球菌（MRSA）
    • 其他病原體類型

第9章：抗菌素抗藥性診斷市場－依技術分類

  • 概述
    • 按技術細分的市場佔有率分析
    • 免疫測定
    • 質譜法
    • 微生物培養
    • 下一代定序（NGS）
    • 聚合酶鍊式反應（PCR）
    • 快速和照護端
    • 其他技術

第 10 章：抗菌素抗藥性診斷市場 - 按最終用途

  • 概述
    • 按最終用途分類的細分市場佔有率分析
    • 診斷實驗室
    • 醫院
    • 製藥和生物技術公司
    • 研究機構
    • 其他

第 11 章：抗菌素抗藥性診斷市場 - 按地理分類

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美抗菌素抗藥性診斷主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模及預測（按病原體類型）
    • 北美市場規模和預測（按技術）
    • 北美市場規模和預測，按最終用途
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲抗菌素抗藥性診斷主要製造商
    • 歐洲市場規模及預測（按國家/地區）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模及預測（按病原體類型）
    • 歐洲市場規模與預測（按技術）
    • 歐洲市場規模和預測，按最終用途
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區抗菌素抗藥性診斷主要製造商
    • 亞太地區市場規模及預測（依國家）
    • 亞太地區市場規模及預測（依產品類型）
    • 亞太地區市場規模及預測（依病原體類型）
    • 亞太地區市場規模及預測（依技術）
    • 亞太地區市場規模及預測（依最終用途）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲抗菌素抗藥性診斷主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（依產品類型）
    • 拉丁美洲市場規模及預測（按病原體類型）
    • 拉丁美洲市場規模及預測（按技術）
    • 拉丁美洲市場規模及預測（依最終用途）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲抗菌素抗藥性診斷主要製造商
    • MEA 市場規模及預測（依國家/地區）
    • MEA 市場規模及預測（依產品類型）
    • MEA 市場規模及預測（依病原體類型）
    • MEA 市場規模及預測（依技術）
    • MEA 市場規模及預測（依最終用途）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其餘地區

第 12 章：主要供應商分析-抗菌素抗藥性診斷產業

  • 競爭基準化分析
    • Competitive Dashboard
    • Competitive Positioning
  • 公司簡介
    • Abbott Laboratories
    • Accelerated Diagnostics, USA
    • Alifax
    • BD
    • Beckman Coulter
    • Becton, Dickinson and Company
    • BioMerieux
    • Bio-Rad Laboratories
    • Danaher
    • F. Hoffmann-La Roche
    • GeneFluidics
    • Hologic, Inc.
    • Molsid
    • OpGen
    • Roche Diagnostics
    • Thermo Fisher Scientific
    • Vela Diagnostics
    • Visby Medical, Inc.
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5383

REPORT HIGHLIGHT

Antimicrobial Resistance Diagnostics Market size was valued at US$ 4,610.22 Million in 2024, expanding at a CAGR of 6.90% from 2025 to 2032.

The Antimicrobial Resistance (AMR) Diagnostics Market is the global industry that focuses on developing, producing, and selling diagnostic tools and technologies to detect antimicrobial-resistant pathogens. These diagnostics help identify resistance patterns in bacteria, viruses, fungi, and parasites. This information allows healthcare providers to prescribe effective treatments and prevent inappropriate use of antimicrobials. The market includes molecular diagnostics, immunoassays, microbiology techniques, and rapid point of care tests used in clinical, hospital, and research settings. As antimicrobial resistance rises worldwide and becomes a serious public health threat, the demand for timely and accurate AMR diagnostics is increasing significantly. This growth is driving innovation and investment in the field.

Antimicrobial Resistance Diagnostics Market- Market Dynamics

Increased adoption of rapid and point-of-care diagnostic technologies to enable timely treatment decisions

Rapid and point-of-care (POC) diagnostic technologies play a crucial role in combating antimicrobial resistance by enabling healthcare professionals to quickly identify resistant infections and tailor treatments accordingly. Unlike conventional laboratory tests that may take days, these advanced diagnostics provide results within minutes or hours, which helps prevent the overuse and misuse of antibiotics.

According to a 2023 World Health Organization (WHO) report, the use of rapid diagnostics has been shown to reduce unnecessary antibiotic prescriptions by up to 30-40%, significantly limiting the development of resistance. Additionally, faster and more accurate detection improves patient outcomes by facilitating timely, targeted therapies, reducing hospital stays, and curbing the spread of infections in healthcare facilities. The increasing availability of portable POC devices also ensures that even remote and resource-limited settings can access critical diagnostic capabilities, bolstering global efforts to contain antimicrobial resistance.

For Instance,

In March 2025, Abbott Laboratories launched a new rapid molecular diagnostic test capable of detecting multiple antimicrobial-resistant pathogens within an hour. This test enhances hospital infection control by enabling quick identification and isolation of resistant infections, improving patient management and antibiotic stewardship.

Antimicrobial Resistance Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.90% over the forecast period (2025-2032)

Based on product type segmentation, reagents & consumables was predicted to show maximum market share in the year 2024

Based on pathogen type segmentation, methicillin-resistant staphylococcus aureus (MRSA) was the leading pathogen type in 2024

Based on technology segmentation, polymerase chain reaction (PCR) was the leading technology in 2024

Based on end use segmentation, hospitals was the leading end use in 2024

On the basis of region, North America was the leading revenue generator in 2024

Antimicrobial Resistance Diagnostics Market- Segmentation Analysis:

The global antimicrobial resistance diagnostics market is segmented on the basis of product type, pathogen type, technology, end use and region.

The market is divided into two categories based on product type: reagents & consumables and instruments. The reagents & consumables sector dominates the market. These components are essential for the testing process, unlike instruments that you might only buy once in a while. Reagents and consumables are needed for every single diagnostic test, which means there's a constant and reliable demand. Healthcare facilities and labs are always on the lookout to restock their supplies to keep their testing operations running smoothly. Reagents and consumables work well with different diagnostic platforms, including molecular diagnostics, immunoassays, and culture-based methods. This broad compatibility increases their use in various testing environments. As a result, hospitals, diagnostic labs, and point-of-care facilities consistently need these products. New technology in diagnostics often results in the creation of new reagents designed for specific tests, which grows the market even more. The pricing models for reagents and consumables benefit manufacturers since consumables provide steady revenue, unlike the less frequent sales of instruments.

The market is divided into five categories based on end-use: hospitals, diagnostic laboratories, pharmaceutical & biotechnology companies, research institutes and others. The hospitals sector dominates the market and this dominance stems from hospitals being the primary points of care where infections are frequently diagnosed and treated. Due to the high risk of hospital-acquired infections and the critical need to manage antimicrobial resistance, hospitals invest heavily in advanced diagnostic tools to ensure timely and accurate detection of resistant pathogens. Moreover, hospitals often have the infrastructure, trained personnel, and funding to implement sophisticated AMR diagnostics, driving substantial demand. Their role in infection control programs and antibiotic stewardship further underscores their importance as a key end user in this market.

Antimicrobial Resistance Diagnostics Market- Geographical Insights

North America dominates the global antimicrobial resistance diagnostics market, holding a 45.71% market share in 2024.

North America remains the largest and most mature market for antimicrobial resistance diagnostics, supported by advanced healthcare infrastructure, extensive research and development activities, and high healthcare spending. The presence of leading diagnostic companies, coupled with comprehensive antimicrobial stewardship programs and government-backed initiatives such as the U.S. National Action Plan for Combating Antibiotic-Resistant Bacteria, has accelerated the adoption of sophisticated diagnostic tools. Hospitals and clinical laboratories in this region prioritize early and accurate detection of resistant pathogens to improve patient outcomes and reduce healthcare-associated infections. Additionally, strong reimbursement frameworks and regulatory support further drive market growth by encouraging investment in innovative diagnostics.

Asia Pacific is estimated to register the highest CAGR in the antimicrobial resistance diagnostics market during the forecast period in 2024.

The Asia-Pacific region, meanwhile, is the fastest-growing market due to a confluence of factors including a rapidly expanding population, increasing urbanization, and rising incidence of infectious diseases with resistant strains. Countries such as China, India, Japan, and South Korea are experiencing significant improvements in healthcare infrastructure, with increased focus on infectious disease management and diagnostic capacity. Governments in the region are actively launching awareness campaigns and implementing policies to monitor and control AMR, which boost demand for rapid and cost effective diagnostic solutions. Moreover, the growing middle class population and improved access to healthcare facilities create a larger patient base seeking timely diagnosis and treatment. The combination of rising prevalence of multidrug-resistant infections, greater healthcare funding, and partnerships between local and international diagnostic firms positions Asia-Pacific as a high-potential market with robust growth prospects over the coming decade.

Antimicrobial Resistance Diagnostics Market- Competitive Landscape:

The antimicrobial resistance (AMR) diagnostics market features a competitive landscape characterized by the presence of several global and regional players focusing on innovation, strategic collaborations, and product launches to strengthen their market position. Leading companies invest heavily in research and development to introduce rapid, accurate, and cost-effective diagnostic solutions that cater to the growing demand for timely detection of resistant pathogens.

Key players in the market include Roche Diagnostics, Abbott Laboratories, bioMerieux, Danaher Corporation (Cepheid), QIAGEN, and Thermo Fisher Scientific. These companies leverage their extensive product portfolios and strong distribution networks to maintain a competitive edge. They also engage in partnerships with healthcare institutions and governments to expand their market reach and support AMR surveillance programs.

The market is marked by frequent technological advancements such as the development of multiplex molecular assays and point of care testing platforms, which provide faster and more precise results. Additionally, mergers and acquisitions are common strategies employed to enhance capabilities and enter new markets. Overall, competition drives continuous innovation, ensuring better diagnostic accuracy and patient outcomes in the fight against antimicrobial resistance.

Recent Developments:

In March 2025, bioMerieux received FDA 510(k) clearance for its VITEK COMPACT PRO, a next-generation system combining microorganism identification and antibiotic susceptibility testing. This launch enhances clinical labs' capabilities to rapidly detect resistant pathogens, thereby supporting targeted treatments and improving patient management in the fight against AMR

In July 2024, QIAGEN announced a collaboration with a global healthcare provider to deploy its QIAstat-Dx Analyzer in regional clinics for rapid AMR diagnostics. This partnership aims to improve access to quick and accurate resistance testing outside traditional hospital settings, supporting early intervention

In September 2024, Thermo Fisher Scientific launched a new PCR-based diagnostic kit designed to rapidly detect antimicrobial-resistant pathogens in hospital settings. This innovation strengthens Thermo Fisher's position in the AMR diagnostics space by offering fast, accurate testing critical for effective antibiotic stewardship

In July 2022, Boehringer Ingelheim, a leading research-driven biopharmaceutical company, along with the life sciences company Evotec SE and bioMerieux, announced a joint venture to develop the next generation of antimicrobials and actionable diagnostics to combat AMR. This collaboration helped the company broaden its product offerings for AMR diagnosis

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Accelerated Diagnostics, USA
  • Alifax
  • BD
  • Beckman Coulter
  • Becton, Dickinson and Company
  • BioMerieux
  • Bio-Rad Laboratories
  • Danaher
  • F. Hoffmann-La Roche
  • GeneFluidics
  • Hologic, Inc.
  • Molsid
  • OpGen
  • Roche Diagnostics
  • Thermo Fisher Scientific
  • Vela Diagnostics
  • Visby Medical, Inc.
  • Others

GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Reagents & Consumables
  • Instruments

GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTICS MARKET, BY PATHOGEN TYPE- MARKET ANALYSIS, 2019 - 2032

  • Clostridium difficile (CD)
  • Drug-resistant campylobacter (DRC)
  • Drug-resistant Neisseria gonorrhoeae (DRNG)
  • Drug-resistant streptococcus pneumoniae (DRSP)
  • Methicillin-resistant Staphylococcus aureus (MRSA)
  • Other pathogen types

GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTICS MARKET, BY TECHNOLOGY - MARKET ANALYSIS, 2019 - 2032

  • Immunoassay
  • Mass spectrometry
  • Microbiology culture
  • Next generation sequencing (NGS)
  • Polymerase chain reaction (PCR)
  • Rapid & point of care
  • Other technologies

GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTICS MARKET, BY END USE - MARKET ANALYSIS, 2019 - 2032

  • Diagnostic Laboratories
  • Hospitals
  • Pharmaceutical & Biotechnology Companies
  • Research Institutes
  • Others

GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Antimicrobial Resistance Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Antimicrobial Resistance Diagnostics Market Snippet by Product Type
    • 2.1.2. Antimicrobial Resistance Diagnostics Market Snippet by Pathogen Type
    • 2.1.3. Antimicrobial Resistance Diagnostics Market Snippet by Technology
    • 2.1.4. Antimicrobial Resistance Diagnostics Market Snippet by End Use
    • 2.1.5. Antimicrobial Resistance Diagnostics Market Snippet by Country
    • 2.1.6. Antimicrobial Resistance Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Antimicrobial Resistance Diagnostics Key Market Trends

  • 3.1. Antimicrobial Resistance Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Antimicrobial Resistance Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Antimicrobial Resistance Diagnostics Market Opportunities
  • 3.4. Antimicrobial Resistance Diagnostics Market Future Trends

4. Antimicrobial Resistance Diagnostics Industry Study

  • 4.1. PESTEL Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Antimicrobial Resistance Diagnostics Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Antimicrobial Resistance Diagnostics Market Landscape

  • 6.1. Antimicrobial Resistance Diagnostics Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Antimicrobial Resistance Diagnostics Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Reagents & Consumables
    • 7.1.3. Instruments

8. Antimicrobial Resistance Diagnostics Market - By Pathogen Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Pathogen Type, 2024 & 2032 (%)
    • 8.1.2. Clostridium difficile (CD)
    • 8.1.3. Drug-resistant campylobacter (DRC)
    • 8.1.4. Drug-resistant Neisseria gonorrhoeae (DRNG)
    • 8.1.5. Drug-resistant streptococcus pneumoniae (DRSP)
    • 8.1.6. Methicillin-resistant Staphylococcus aureus (MRSA)
    • 8.1.7. Other pathogen types

9. Antimicrobial Resistance Diagnostics Market - By Technology

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 9.1.2. Immunoassay
    • 9.1.3. Mass spectrometry
    • 9.1.4. Microbiology culture
    • 9.1.5. Next generation sequencing (NGS)
    • 9.1.6. Polymerase chain reaction (PCR)
    • 9.1.7. Rapid & point of care
    • 9.1.8. Other technologies

10. Antimicrobial Resistance Diagnostics Market - By End Use

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End Use, 2024 & 2032 (%)
    • 10.1.2. Diagnostic Laboratories
    • 10.1.3. Hospitals
    • 10.1.4. Pharmaceutical & Biotechnology Companies
    • 10.1.5. Research Institutes
    • 10.1.6. Others

11. Antimicrobial Resistance Diagnostics Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Antimicrobial Resistance Diagnostics Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Antimicrobial Resistance Diagnostics Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Antimicrobial Resistance Diagnostics Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Antimicrobial Resistance Diagnostics Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Antimicrobial Resistance Diagnostics Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Antimicrobial Resistance Diagnostics Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Abbott Laboratories
    • 12.2.2. Accelerated Diagnostics, USA
    • 12.2.3. Alifax
    • 12.2.4. BD
    • 12.2.5. Beckman Coulter
    • 12.2.6. Becton, Dickinson and Company
    • 12.2.7. BioMerieux
    • 12.2.8. Bio-Rad Laboratories
    • 12.2.9. Danaher
    • 12.2.10. F. Hoffmann-La Roche
    • 12.2.11. GeneFluidics
    • 12.2.12. Hologic, Inc.
    • 12.2.13. Molsid
    • 12.2.14. OpGen
    • 12.2.15. Roche Diagnostics
    • 12.2.16. Thermo Fisher Scientific
    • 12.2.17. Vela Diagnostics
    • 12.2.18. Visby Medical, Inc.
    • 12.2.19. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us